Lb Pharmaceuticals Inc (LBRX)

SG&A Expense Growth

31.11%

Quarterly · Period ending:

LBRX logo

LBRX SG&A Expense Growth

Latest reported31.11%
LBRX Quarterly SG&A Growth (QoQ) (0.00% → 31.11%)
High-resolution chart · PNG

LBRX sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lb Pharmaceuticals Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
31.1102%
36.9408%
90.5554%
7.7774%
0%
0%
155.3774%
121.5256%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.